Interference No. 103,891
At the top of page 84 of FX-17, a schematic test strip is shown.
On the left side is a spot of APS antigen and further up is an
immobilized antibody. This forms the positive zone within the
scope of the count. To the right, is one spot of negative rabbit
Ig for the negative zone, and below both positive and negative
zones is a jetted stripe of test zone. FR19. Based on this
evidence, we credit Flanders with a corroborated reduction to
practice on December 22, 1988. Corroboration is furnished by
Ms. Watts, a non-inventor.
Finally, we note the statement in Moorman’s brief that
Moorman has no issue with Flanders’ reduction to practice on
December 22, 1988. Moorman brief at 8-9.
Moorman Priority Case
The following are our findings of fact with respect to
Moorman’s priority case. Starting in late 1987, Moorman began
work on an on board control test strip device for medical diag-
nosis purposes. MR1. Specifically, he worked on a strip to
detect Group A Streptococcal carbohydrate, a molecule indicative
of a streptococcal infection in humans. Id.; MR16-17. Moorman
supervised two assistants–-Lisa Terrett and Dilip Pandya. MR2;
MR3, ¶ 6. In early April 1988, Moorman communicated a test strip
20
Page: Previous 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next
Last modified: November 3, 2007